Repoxygen
Repoxygen was the tradename for a type of gene therapy to produce erythropoietin (EPO). It was under preclinical development by Oxford Biomedica as a possible treatment for anaemia but was abandoned in 2003.
The project became infamous when it was mentioned during the criminal trial of Thomas Springstein, a former track coach for some German athletes, who was found guilty of giving athletes performance enhancing drugs without their knowledge. An email in which Springstein attempted to obtain Repoxygen was read by a prosecutor, which led to a flurry of media coverage.
The World Anti-Doping Agency banned "gene doping" in 2003 and as of 2009 was researching detection methods for substances such as repoxygen.
Sources and credits
This article is adapted from the Wikipedia article “Repoxygen”, written by its contributors and licensed under CC BY-SA 4.0. Fathomly has changed the layout, removed citation markers, navigation and maintenance notices, and adjusted punctuation. This adapted version is shared under the same license. For references, see the original article.
Fathomly is not affiliated with or endorsed by the Wikimedia Foundation. Spotted a problem? Tell us.